(Q34654904)

3 August 2017

title

Stromal disrupting effects of nab-paclitaxel in pancreatic cancer (English)

1 reference

ORCID Public Data File 2021

3 August 2017

1 reference

1 reference

author name string

R Alvarez

1

1 reference

3 August 2017

M Musteanu

2

1 reference

3 August 2017

E Garcia-Garcia

3

1 reference

3 August 2017

P P Lopez-Casas

4

1 reference

3 August 2017

D Megias

5

1 reference

3 August 2017

C Guerra

6

1 reference

3 August 2017

M Muñoz

7

1 reference

3 August 2017

Y Quijano

8

1 reference

3 August 2017

A Cubillo

9

1 reference

3 August 2017

J Rodriguez-Pascual

10

1 reference

3 August 2017

C Plaza

11

1 reference

3 August 2017

E de Vicente

12

1 reference

3 August 2017

S Prados

13

1 reference

3 August 2017

S Tabernero

14

1 reference

3 August 2017

M Barbacid

15

1 reference

3 August 2017

F Lopez-Rios

16

1 reference

3 August 2017

M Hidalgo

17

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 August 2013

1 reference

British Journal of Cancer

3 August 2017

published in

1 reference

3 August 2017

volume

109

1 reference

3 August 2017

issue

4

1 reference

3 August 2017

page(s)

926-933

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.2013.415

3 August 2017

exact match

0 references

cites work

Diagnostic accuracy of quantitative EUS elastography for discriminating malignant from benign solid pancreatic masses: a prospective, single-center study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3749580

nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3749580

Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3749580

Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3749580

Neoadjuvant/preoperative gemcitabine for patients with localized pancreatic cancer: a meta-analysis of prospective studies

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3749580

Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3749580

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3749580

Lack of host SPARC enhances vascular function and tumor spread in an orthotopic murine model of pancreatic carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3749580

Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3749580

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3749580

Tumor-stroma interactions in pancreatic ductal adenocarcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3749580

Significance of pathologic response to preoperative therapy in pancreatic cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3749580

Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3749580

The activated stroma index is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3749580

Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer

26 October 2018

1 reference

12 December 2020

Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma

1 reference

12 December 2020

EUS elastography of the pancreas: feasibility and pattern description of the normal pancreas, chronic pancreatitis, and focal pancreatic lesions

1 reference

12 December 2020

Pancreatic cancer--could it be that simple? A different context of vulnerability

1 reference

12 December 2020

Quantitative endoscopic ultrasound elastography: an accurate method for the differentiation of solid pancreatic masses

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.2013.415

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference

3 August 2017

1 reference